-transparent.png){kind=logo}
The roles and relative contributions of secretory and cytosolic phospholipases A2 in physiology and pathology are not precisely known. In a search for differential inhibitors of these enzymes, which could serve as tools to clarify this issue, we evaluated the potencies of reference compounds and three series of new compounds, viz. substrate analogues, 1,2-amino alcohols and enolized beta-tricarbonyl derivatives, as inhibitors of secretory phospholipase A2 from human polymorphonuclear leukocytes (sPLA2) and of cytosolic phospholipase A2 from human U937 cells (cPLA2). With few exceptions, the compounds selected are potent inhibitors of sPLA2 with IC50 values (concentration inhibiting 50%) in the low micromolar range. Inhibition of cPLA2 was only observed with some phosphate-free substrate analogues, with 1,2-amino alcohols and two of seven reference compounds. These results suggest that inhibition of secretory and of cytosolic phospholipases A2 are independent effects. Several inhibitors could be identified with a marked selectivity for sPLA2.
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
February 2000,
Journal of immunology (Baltimore, Md. : 1950),
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
January 1993,
Agents and actions,
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
November 1998,
Biochimica et biophysica acta,
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
January 1998,
The Biochemical journal,
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
November 1998,
Journal of immunology (Baltimore, Md. : 1950),
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
October 1997,
Biochimica et biophysica acta,
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
May 2004,
Virchows Archiv : an international journal of pathology,
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
April 1994,
European journal of biochemistry,
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
July 2012,
Critical care medicine,
F Märki, and
W Breitenstein, and
E Beriger, and
R Bernasconi, and
G Caravatti, and
J E Francis, and
R Paioni, and
H U Wehrli, and
R Wiederkehr
October 1995,
Journal of lipid mediators and cell signalling,
